Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 10 2021 - 4:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2021
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
|
BELLUS Health Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: May 10, 2021
|
By:
|
/s/ Ramzi Benamar
|
|
|
|
Name:
|
Ramzi Benamar
|
|
|
|
Title:
|
Chief Financial Officer
|
|
Form 6-K Exhibit Index
Exhibit
Number
|
|
Document Description
|
|
|
|
|
|
|
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Aug 2024 to Sep 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Sep 2023 to Sep 2024